• 1
    Hedinger C, Williams ED, Sobin LH. Histological typing of thyroid tumors, volume 11. Berlin: Springer, 1988.
  • 2
    Rosen IB, Azadian A, Walfish PG. Adverse aspects of small thyroid cancer and need for treatment. Head Neck. 1995; 17: 373376.
  • 3
    Gemsenjager E, Schweizer I. Small thyroid carcinomas: biological characteristics, diagnosis and therapy. Schweiz Med Wochenschr. 1999; 129: 681690.
  • 4
    Sampson RJ, Oka H, Key CR, Buncher CR, Iijima S. Metastases from occult thyroid carcinoma. An autopsy study from Hiroshima and Nagasaki, Japan. Cancer. 1970; 25: 803811.
  • 5
    Chow SM, Law SC, Au SK, et al. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute. Head Neck. 2002; 24: 670677.
  • 6
    Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period [see discussion]. Surgery. 1992; 112: 11391147.
  • 7
    Baudin E, Travagli JP, Ropers J, et al. Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer. 1998; 83: 553559.
  • 8
    Yamashita H, Noguchi S, Murakami N, et al. Extracapsular invasion of lymph node metastasis. A good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma. Cancer. 1999; 86: 842849.
  • 9
    Appetecchia M, Scarcello G, Pucci E, Procaccini A. Outcome after treatment of papillary thyroid microcarcinoma. J Exp Clin Cancer Res. 2002; 21: 159164.
  • 10
    Rassael H, Thompson LD, Heffess CS. A rationale for conservative management of microscopic papillary carcinoma of the thyroid gland: a clinicopathologic correlation of 90 cases. Eur Arch Otorhinolaryngol. 1998; 255: 462467.
  • 11
    Furlan JC, Bedard Y, Rosen IB. Biologic basis for the treatment of microscopic, occult well-differentiated thyroid cancer. Surgery. 2001; 130: 10501054.
  • 12
    Bisi H, Fernandes VS, de Camargo RY, Koch L, Abdo AH, de Brito T. The prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma. Cancer. 1989; 64: 18881893.
  • 13
    Yamamoto Y, Maeda T, Izumi K, Otsuka H. Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer. 1990; 65: 11731179.
  • 14
    Bramley MD, Harrison BJ. Papillary microcarcinoma of the thyroid gland. Br J Surg. 1996; 83: 16741683.
  • 15
    Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer. 1985; 56: 531538.
  • 16
    Fink A, Tomlinson G, Freeman JL, Rosen IB, Asa SL. Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms. Mod Pathol. 1996; 9: 816820.
  • 17
    Fukunaga FH, Yatani R. Geographic pathology of occult thyroid carcinomas. Cancer. 1975; 36: 10951099.
  • 18
    Delides GS, Elemenoglou J, Lekkas J, Kittas C, Evthimiou C. Occult thyroid carcinoma in a Greek population. Neoplasma. 1987; 34: 119125.
  • 19
    Kasai N, Sakamoto A. New subgrouping of small thyroid carcinomas. Cancer. 1987; 60: 17671770.
  • 20
    Bondeson L, Ljungberg O. Occult thyroid carcinoma at autopsy in Malmo, Sweden. Cancer. 1981; 47: 319323.
  • 21
    Chow S-M, Law SCK, Au S-K, et al. Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong 1960–2000. Clin Oncol. In press.
  • 22
    Noguchi S. Differentiated thyroid carcinomas in Japan: our own experience and review of the literature. Thyroidol Clin Exp. 1998; 10: 4150.
  • 23
    Yang GC, LiVolsi VA, Baloch ZW. Thyroid microcarcinoma: fine-needle aspiration diagnosis and histologic follow-up. Int J Surg Pathol. 2002; 10: 133139.
  • 24
    Chung WY, Chang HS, Kim EK, Park CS. Ultrasonographic mass screening for thyroid carcinoma: a study in women scheduled to undergo a breast examination. Surg Today. 2001; 31: 763767.
  • 25
    Chow SM, Law SC, Mendenhall WM, et al. Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol Biol Phys. 2002; 52: 784795.
  • 26
    Sobin LH, Wittlekind C. UICC TNM classification of malignant tumours, 5th edition. New York: Wiley-Liss, Inc., 1997.
  • 27
    Fleming I, Cooper JS, Henson DE, et al. AJCC cancer staging manual, 5th edition. New York: Springer-Verlag, 1997.
  • 28
    Cox DR. Regression models and life tables. J R Statist Soc B. 1972; 34: 187202.
  • 29
    Hong Kong Cancer Registry. Cancer incidence and mortality in Hong Kong, 1998–1999. Hong Kong: Hong Kong Cancer Registry, 2000.
  • 30
    Sugitani I, Fujimoto Y. Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocrine J. 1999; 46: 209216.
  • 31
    Hughes CJ, Shaha AR, Shah JP, Loree TR. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck. 1996; 18: 127132.
  • 32
    Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994; 97: 418428.
  • 33
    Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993; 114: 10501057; discussion, 1057–1058.
  • 34
    Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer. 1985; 55: 794804.
  • 35
    Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992; 75: 714720.
  • 36
    DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990; 71: 414424.
  • 37
    Loh KC, Greenspan FS, Gee L, Miller TR, Yeo PP. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab. 1997; 82: 35533562.
  • 38
    Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer. 1998; 82: 375388.
  • 39
    Hay ID, McConahey WM, Goellner JR. Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2512 consecutive patients during 1940 through 2000. Trans Am Clin Climatol Assoc. 2002; 113: 241260.
  • 40
    Samaan NA, Schultz PN, Haynie TP, Ordonez NG. Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients. J Clin Endocrinol Metab. 1985; 60: 376380.
  • 41
    Schlumberger M, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med. 1996; 37: 598605.
  • 42
    Massin JP, Savoie JC, Garnier H, Guiraudon G, Leger FA, Bacourt F. Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment. Cancer. 1984; 53: 982992.
  • 43
    Casara D, Rubello D, Saladini G, et al. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med. 1993; 34: 16261631.
  • 44
    Chow SM, Law SC, Mendenhall M, et al. Follicular thyroid carcinoma: prognostic factors and the role of radioiodine. Cancer. 2002; 95: 488498.
  • 45
    Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the mayo clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg. 2002; 26: 879885.
  • 46
    Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001; 86: 14471463.
  • 47
    Qubain SW, Nakano S, Baba M, Takao S, Aikou T. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery. 2002; 131: 249256.
  • 48
    Guidelines for the management of thyroid cancer in adults. London: British Thyroid Association and Royal College of Physicians of London, 2002.
  • 49
    Gimm O, Dralle H. The current surgical approach to non-medullary thyroid cancer. In: BiersackHJ, GrunwaldF, editors. Thyroid cancer, 1st edition. Bonn: Springer, 2001: 8289.
  • 50
    Sugitani I, Yanagisawa A, Shimizu A, Kato M, Fujimoto Y. Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy. World J Surg. 1998; 22: 731737.